logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Pharmakea, Inc.


USPTO Granted Patents = 19

% Expired Patents = 21.1


Forward Citations = 60

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal John Howard Hutchinson (15 out of 112 patents)

silverMedal Martin W Rowbottom (12 out of 41 patents)

bronzeMedal David Gregory Lonergan (11 out of 21 patents)

4.  Imelda Calderon (4 out of 12 patents)

5.  Kevin Ross Holme (2 out of 6 patents)

6.  Jillian Frances Evans (2 out of 9 patents)

7.  Timothy Andrew Parr (2 out of 12 patents)

8.  Kevin Duane Bunker (1 out of 46 patents)

9.  Gretchen Bain (1 out of 3 patents)

10.  Fei Huang (1 out of 1 patent)

11.  Andiliy Gokching Lai (1 out of 19 patents)

12.  Deidre A MacKenna (1 out of 7 patents)

13.  Deidre A Mackenna (0 patent)


19 patents:

1. 11793797 - Uses of a lysyl oxidase-like 2 inhibitor (2023-10-24),
2. 11459309 - Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making (2022-10-04),
3. 11358936 - Lysyl oxidase-like 2 inhibitors and uses thereof (2022-06-14),
4. 11345676 - Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds (2022-05-31),
5. 11072585 - Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof (2021-07-27),
6. 11058676 - Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof (2021-07-13),
7. 10774069 - Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making (2020-09-15),
8. 10766860 - Lysyl oxidase-like 2 inhibitors and uses thereof (2020-09-08),
9. 10588900 - Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof (2020-03-17),
10. 10570094 - Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof (2020-02-25),
11. 10150732 - Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof (2018-12-11),
12. 9999615 - Autotaxin inhibitor compounds (2018-06-19),
13. 9951026 - Heterocyclic vinyl autotaxin inhibitor compounds (2018-04-24),
14. 9926318 - Tetracyclic autotaxin inhibitors (2018-03-27),
15. 9850203 - Autotaxin inhibitor compounds (2017-12-26),
Company Overview
Pharmakea, Inc. is a biotechnology company based in San Diego, California, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing advanced technologies to create novel treatments, particularly in the fields of oncology and autoimmune diseases. With a commitment to scientific excellence, Pharmakea aims to address unmet medical needs through its research initiatives and collaborative efforts, positioning itself as a key player in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Pharmakea, Inc. USPTO Patent Assignee Logo
19 Patents

#313 in San Diego, CA

#4,105 in California

#17,150 in US

#32,693 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Pharmakea, Inc.

Forward Citations = 60

13 inventors:

goldMedal John Howard Hutchinson (15 out of 112 patents)

silverMedal Martin W Rowbottom (12 out of 41 patents)

bronzeMedal David Gregory Lonergan (11 out of 21 patents)

4.  Imelda Calderon (4 out of 12 patents)

5.  Kevin Ross Holme (2 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharmakea, Inc.. Retrieved from https://idiyas.com/company/pharmakea

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…